Division of Pediatric Urology, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee; Division of Pediatric Urology, Children's Hospital of Pittsburgh (HAS), Pittsburgh, Pennsylvania.
Division of Pediatric Urology, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee; Division of Pediatric Urology, Children's Hospital of Pittsburgh (HAS), Pittsburgh, Pennsylvania.
J Urol. 2016 Apr;195(4 Pt 2):1239-44. doi: 10.1016/j.juro.2015.11.034. Epub 2016 Feb 28.
Sacral neuromodulation has been demonstrated to improve refractory bowel bladder dysfunction in children. The purpose of the current study was to determine whether results are durable in children after longer followup, whether children with a lower body mass index are at risk for device failure and whether pretreatment urodynamic evaluation can predict posttreatment outcome.
Pediatric patients with refractory bowel bladder dysfunction were enrolled following informed consent and followed prospectively. All patients underwent preoperative videourodynamic evaluation and a 2-stage implantation procedure. Validated questionnaires were used to assess symptom severity and quality of life. Complications were analyzed with regard to treatment required and patient body mass index.
During 45 months 30 patients were enrolled. Median age was 8.3 years at enrollment. Median followup was 14.8 months. Patients had significant improvement in quality of life and symptom scores, which persisted at the most recent followup. Patients who had uninhibited detrusor contractions on preoperative urodynamic assessment had significantly greater improvement in symptoms. Of the patients 23% had a complication requiring reoperation, most commonly neurostimulator lead breakage in those with a significantly lower body mass index.
Sacral neuromodulation significantly improves quality of life and symptom severity in children with refractory bowel bladder dysfunction. Children gain greater benefit if they show uninhibited bladder contractions on preoperative urodynamic evaluation. Children have a high rate of lead breakage requiring operative revision, which was seen after minor trauma in those with a lower body mass index.
骶神经调节已被证明可改善儿童难治性肠膀胱功能障碍。本研究的目的是确定在更长的随访时间后,儿童的结果是否持久,体重指数较低的儿童是否存在设备故障风险,以及术前尿动力学评估是否可以预测治疗后的结果。
在获得知情同意并进行前瞻性随访后,招募了患有难治性肠膀胱功能障碍的儿科患者。所有患者均接受术前视频尿动力学评估和 2 期植入手术。使用经过验证的问卷评估症状严重程度和生活质量。分析并发症与治疗所需和患者体重指数的关系。
在 45 个月期间,共招募了 30 名患者。入组时的中位年龄为 8.3 岁。中位随访时间为 14.8 个月。患者的生活质量和症状评分均有显著改善,且在最近的随访中仍持续存在。术前尿动力学评估中存在逼尿肌无抑制收缩的患者,其症状改善更为显著。在患者中,23%的患者出现并发症需要再次手术,最常见的是神经刺激器导联断裂,这种情况多见于体重指数明显较低的患者。
骶神经调节可显著改善患有难治性肠膀胱功能障碍的儿童的生活质量和症状严重程度。如果儿童在术前尿动力学评估中显示出逼尿肌无抑制收缩,则可获得更大的益处。儿童的导联断裂发生率较高,需要手术修复,体重指数较低的儿童在受到轻微创伤后更容易出现这种情况。